Large-scale testing (Phase 3)Study completedNCT02321397
What this trial is testing
To Demonstrate Equivalence in Analgesic Efficacy & Bowel Function Between OXN PR Higher Dose & Lower Dose Tablet Strengths in Subjects With Non-cancer or Cancer Pain
Who this might be right for
Malignant PainNon-malignant Pain
Mundipharma Research GmbH & Co KG 155